CSPC Pharmaceutical Group Balance Sheet Health
Financial Health criteria checks 5/6
CSPC Pharmaceutical Group has a total shareholder equity of CN¥36.5B and total debt of CN¥388.9M, which brings its debt-to-equity ratio to 1.1%. Its total assets and total liabilities are CN¥47.9B and CN¥11.4B respectively. CSPC Pharmaceutical Group's EBIT is CN¥6.4B making its interest coverage ratio -29.4. It has cash and short-term investments of CN¥10.8B.
Key information
1.1%
Debt to equity ratio
CN¥388.87m
Debt
| Interest coverage ratio | -29.4x |
| Cash | CN¥10.82b |
| Equity | CN¥36.47b |
| Total liabilities | CN¥11.42b |
| Total assets | CN¥47.90b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 1093's short term assets (CN¥26.5B) exceed its short term liabilities (CN¥10.4B).
Long Term Liabilities: 1093's short term assets (CN¥26.5B) exceed its long term liabilities (CN¥988.7M).
Debt to Equity History and Analysis
Debt Level: 1093 has more cash than its total debt.
Reducing Debt: 1093's debt to equity ratio has increased from 0.3% to 1.1% over the past 5 years.
Debt Coverage: 1093's debt is well covered by operating cash flow (1101.6%).
Interest Coverage: 1093 earns more interest than it pays, so coverage of interest payments is not a concern.